Medline Inc.

MDLN Nasdaq SEC CIK 2046386
Follow Medline Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $7.9B +10.4% vs same quarter last year
Net income $318M +0% vs same quarter last year
EPS, diluted $0.22
Operating cash flow $1B +61.2% vs same quarter last year
Revenue by quarter
$6.6B
$6.9B
$7.1B
$7.8B
$7.4B
$7.7B
$7.9B
Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income3 fiscal years
$0$10B$20B$30BFY23FY24FY25
Show the numbers
YearRevenue
FY25$28.4B
FY24$25.5B
FY23$23.2B
MarginsShare of revenue
  • Gross margin
  • Operating margin
0%10%20%30%FY23FY24FY25
Show the numbers
YearGross marginOperating margin
FY2526.4%7.8%
FY2427.3%8.4%
FY2325.3%5.4%
Free cash flowOperating cash flow minus capital expenditure
$0$500M$1B$1.5BFY23FY24FY25
Show the numbers
YearFree cash flow
FY25$1.3B
FY24$1.4B
FY23$1.4B
Returned to shareholdersDividends paid and shares bought back
$0$10M$20M$30M$40MFY23FY24FY25
Show the numbers
YearBuybacks
FY25$33M
FY24$20M
FY23$0